IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v537y2016i7621d10.1038_nature19353.html
   My bibliography  Save this article

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

Author

Listed:
  • Marco Sciacovelli

    (Medical Research Council Cancer Unit, University of Cambridge)

  • Emanuel Gonçalves

    (European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute (EBI))

  • Timothy Isaac Johnson

    (Medical Research Council Cancer Unit, University of Cambridge)

  • Vincent Roberto Zecchini

    (Medical Research Council Cancer Unit, University of Cambridge)

  • Ana Sofia Henriques da Costa

    (Medical Research Council Cancer Unit, University of Cambridge)

  • Edoardo Gaude

    (Medical Research Council Cancer Unit, University of Cambridge)

  • Alizee Vercauteren Drubbel

    (Medical Research Council Cancer Unit, University of Cambridge)

  • Sebastian Julian Theobald

    (Medical Research Council Cancer Unit, University of Cambridge)

  • Sandra Riekje Abbo

    (Medical Research Council Cancer Unit, University of Cambridge)

  • Maxine Gia Binh Tran

    (Uro-Oncology Research Group, University of Cambridge
    †Present address: UCL Division of Surgery and Interventional Science, Renal Cancer Centre, Royal Free Hospital, Pond Street, London NW3 2QG, UK.)

  • Vinothini Rajeeve

    (Integrative Cell Signalling and Proteomics, Centre for Haemato-Oncology, John Vane Science Centre, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square)

  • Simone Cardaci

    (Cancer Research UK Beatson Institute)

  • Sarah Foster

    (Development and Neuroscience, University of Cambridge)

  • Haiyang Yun

    (Cambridge Institute for Medical Research and Addenbrooke’s Hospital, and Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge)

  • Pedro Cutillas

    (Integrative Cell Signalling and Proteomics, Centre for Haemato-Oncology, John Vane Science Centre, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square)

  • Anne Warren

    (University of Cambridge)

  • Vincent Gnanapragasam

    (Academic Urology Group, University of Cambridge)

  • Eyal Gottlieb

    (Cancer Research UK Beatson Institute)

  • Kristian Franze

    (Development and Neuroscience, University of Cambridge)

  • Brian Huntly

    (Cambridge Institute for Medical Research and Addenbrooke’s Hospital, and Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge)

  • Eamonn Richard Maher

    (University of Cambridge
    NIHR Cambridge Biomedical Research Centre)

  • Patrick Henry Maxwell

    (Cambridge Institute for Medical Research, University of Cambridge)

  • Julio Saez-Rodriguez

    (European Molecular Biology Laboratory (EMBL), European Bioinformatics Institute (EBI)
    RWTH Aachen University, Faculty of Medicine, Joint Research Center for Computational Biomedicine)

  • Christian Frezza

    (Medical Research Council Cancer Unit, University of Cambridge)

Abstract

Accumulation of fumarate resulting from mutations in fumarate hydratase,which are associated with renal and other cancers, is shown to induce epithelial-to-mesenchymal transition—a process associated with cancer initiation.

Suggested Citation

  • Marco Sciacovelli & Emanuel Gonçalves & Timothy Isaac Johnson & Vincent Roberto Zecchini & Ana Sofia Henriques da Costa & Edoardo Gaude & Alizee Vercauteren Drubbel & Sebastian Julian Theobald & Sandr, 2016. "Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition," Nature, Nature, vol. 537(7621), pages 544-547, September.
  • Handle: RePEc:nat:nature:v:537:y:2016:i:7621:d:10.1038_nature19353
    DOI: 10.1038/nature19353
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature19353
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature19353?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:537:y:2016:i:7621:d:10.1038_nature19353. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.